Adalimumab efficacious adjunct to surgery for hidradenitis suppurativa
Healthcare musicians can uplift families with premature infants during intensive care, research suggests
18 August 2021Videos capture lethal progress of COVID-19 virus
18 August 2021Adalimumab efficacious adjunct to surgery for hidradenitis suppurativa
(HealthDay)—For patients with moderate-to-severe hidradenitis suppurativa (HS), adalimumab is efficacious in conjunction with wide-excision surgery followed by secondary intention healing, according to a study published online Aug. 18 in JAMA Surgery.
